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Dr. Kamal Karda arrived at her office Monday morning and was greeted with an urgent phone 
call from the Minister of Health. Newly appointed as the President of the Public Health Agency 
of Canada (PHAC), Dr. Karda had yet to settle into her new role. As she answered the phone, 
she could only imagine what information awaited her. Amongst her many priorities, she had 
been informed that Lyme disease would be a key component of the Minister’s mandate and, as 
President of PHAC, Dr. Karda was expected to conduct a thorough analysis to formulate a plan 
on tackling the impact of and the issues surrounding Lyme disease in Canada. She was aware 
of the challenges surrounding Lyme disease and planned to draw on resources within the 
Agency to help shape her next course of action. She contemplated the roles of surveillance, 
policy, and communications as she gathered her thoughts. One thing was for certain: the margin 
of error was minimal to none. Her ability to formulate a plan would depend on strategic decision 
making, strong communication skills, and resourcefulness.    
 
BACKGROUND  
Lyme disease is a tick-borne zoonosis caused by Borrelia Burgdorferi (Wormser, G. P. 2006). It 
has been known to illicit multisystem inflammatory disease symptoms. Rodents and ticks are 
the primary reservoirs of the disease. Lyme disease is primarily seen in the northern 
hemisphere and is the most commonly reported vector-borne disease in the United States, with 
an increase in cases being detected in Canada due to climate change. Lyme disease is 
characteristically known for a bullseye-shaped rash that appears at the bite site; however, this is 
not always the case.  
 
The Public Health Agency of Canada (PHAC) engages in surveillance activity (PHAC, 2018). Of 
the many vector-borne diseases, Lyme disease has gained a significant amount of attention by 
the media in recent years due to rising incidences. Throughout the better part of two decades, 
various guidance documents have been formulated for Lyme disease as well as surveillance 
methods to help monitor the disease; however, minimal increases to funding have been 
granted. Currently, active surveillance is the primary way to gather data. However, in recent 
years, a push for passive surveillance has begun, due to the knowledge that many individuals 
who suffer from Lyme disease are not represented in the active surveillance data set.  
 
Currently, PHAC relies on provincial governments to share data regarding confirmed cases of 
Lyme disease in order to track incidences and monitor trends. This form of active surveillance, 
while beneficial, has some pitfalls. Because of the unique clinical presentation of Lyme disease, 
it is not uncommon for some diagnoses to be missed, resulting in what patients and advocacy 
groups call “Chronic Lyme Disease.” Chronic Lyme disease is believed to be a lingering, 
debilitating, clinical manifestation in patients who have been living with undiagnosed Lyme 
disease or Lyme disease that was diagnosed late in its clinical onset and thus, was not treated 
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immediately. While there is no conclusive medical literature to solidify the existence of Chronic 
Lyme disease, there is a clear consensus on the use of antibiotic therapy upon immediate 
detection of Lyme disease. Therapy often consists of three readily available antibiotics: 
Doxycycline, Amoxicillin, and Cefuroxime (PHAC, 2017). The fact that many Canadians travel to 
the United States for diagnosis and treatment makes gathering the data required to inform 
policy and best practices even more problematic. There is a growing movement from those 
affected by the disease to garner more funding for acute care management. The belief 
surrounding this train of thought stems from the ideology that those suffering from Lyme disease 
do not have enough avenues for diagnosis, treatment, and rehabilitation. 
 
To address the challenges of surveillance, analysts within PHAC tabled a proposal to create an 
online Lyme disease survey. The goal of the survey is to consolidate information from Canadian 
patients who have been diagnosed within and outside of Canada. The ability to create this form 
of passive data gathering, combined with existing active surveillance, would allow PHAC to use 
a larger, more comprehensive data set to aid in decision making. Guidance documents, such as 
the Canadian Lyme disease framework tabled in the early 2000s, emphasized surveillance and 
preventative interventions such as increasing awareness in provincial parks and educating 
health professionals to improve diagnosis and reporting. Evidence-based studies have not 
yielded the necessary data to indicate a drastic increase in funding for Lyme disease in regards 
to acute care, clinics, and altering current diagnostic testing. The current government has 
prioritized mental health and chronic disease prevention, and, as such, the majority of funding 
has been reserved for these causes. PHAC’s role is to continue surveillance and provide 
guidance through best practices to the public as well as healthcare professionals in order to 
help in the management and detection of Lyme disease. PHAC does not have the ability to 
mandate regulatory initiatives and acts solely as a guidance agency for provincial governments 
in regards to Lyme disease.  
 
The phone call from the Minister did not surprise Dr. Karda. In recent years, there had been 
increasing pressure from advocacy groups such as The Canadian Lyme Disease Foundation 
(CanLyme) to increase funding. CanLyme is a registered non-profit charitable organization that 
is run by volunteers throughout Canada (CanLyme, 2017). CanLyme advocates for better 
funding of acute care services for those currently infected with Lyme disease. CanLyme argues 
that funding should be allocated for improved treatment and more reliable diagnostic options, 
such as dedicated diagnostic testing sites, improved testing, specific Lyme clinics, and broader 
use of antibiotics. While PHAC has engaged CanLyme in discussions about these issues, in 
recent years, there has been resistance on the part of the advocacy group due to their 
perception of the federal government not responding. CanLyme states that it is dedicated to 
promoting research, education, diagnosis, and treatment of Lyme disease (CanLyme, 2017), 
which is also aligned with PHAC’s goals. However, PHAC has put emphasis on prevention, 
maintaining that Lyme disease is entirely preventable, and, with the correct precautions, the 
incidences could be greatly reduced, if not eradicated. Dr. Karda understood the frustrations of 
the advocacy group but wanted to maintain the Agency’s evidence-based approach to public 
health practice. Keeping an open line of communication with CanLyme would be integral to 
bridging the divide between the two points of view. 
 
The Lyme disease unit is a part of the Centre for Food-borne, Environmental and Zoonotic 
Infectious Diseases at PHAC (CFEZID) (PHAC, 2017). Headed by Epidemiologist Justin Gera, 
the unit conducts Lyme disease surveillance and, over the course of two years, has hired 
additional staff to assist with the increasing workload. Funding within the government is often a 
key issue, and while the costs associated with Lyme disease were rising, the data analyses 
within the Lyme disease unit suggested that focusing on prevention would yield the highest net 
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savings to the health care system. Preliminary analyses produced by Gera and the Lyme 
disease unit indicate that resource allocation towards prevention would result in the greatest 
impact on the health and wellbeing of Canadians, while also providing the most value for the 
funding allocated towards Lyme disease. Dr. Karda’s top priority was allocating resources in an 
optimal way, aligned with evidence-based analysis. 
 
While PHAC gathered information through surveillance and literature reviews, CanLyme 
garnered media attention and public support for Lyme disease funding. As the number of 
patients who suffered from Lyme disease increased, the ability to relay genuine heartfelt stories 
of those affected created a flurry of negative attention towards PHAC and highlighted the 
Agency’s perceived inability to respond to calls for increased funding. Frustrations were 
beginning to rise on both sides, and within PHAC, media attention and pressure from CanLyme 
was creating conflicting ideologies with regards to the allocation of funds (preventative, 
treatment, testing, or a combination). Dr. Karda knew how crucial evidence-based public health 
principles were for bridging the gap between knowledge and application (Brownson, Fielding & 
Green, 2018). 
 
Dr. Karda is tasked with garnering the support of her staff to deliver a unified message while 
supporting the Minister’s mandate, acknowledging and addressing the advocacy group’s 
concerns, and being fiscally responsible to the Canadian public. She must navigate the hurdles 
of building relationships with the various stakeholders (CanLyme, healthcare providers, public 
and patients, media, provincial governments, and PHAC employees) and exercising her 
leadership skills. Dr. Karda acknowledges the many systemic healthcare gaps and the natural 
frustration that accompanies delays in receiving care. As she continued to gather information for 
her analysis, she focused on maintaining an open dialogue with both the employees at PHAC 
and the patient advocacy group CanLyme.  
 
Dr. Karda is now tasked with bridging the gap between her employees, the Minister, and the 
public’s pressure and perception of PHAC’s role and leadership in Lyme disease prevention and 
management. Precautions such as body checks after walking in high exposure areas are seen 
as the gold standard in early detection and treatment of Lyme disease and is an area that PHAC 
can promote to the public (PHAC, 2018). She also acknowledges that those suffering from 
Lyme disease rightfully would like answers that lead to immediate relief. There are more than 
adequate reserves for the antibiotics needed to treat Lyme disease, and there is no evidence 
indicating that creating Lyme-specific clinics would yield a change in incidences of the disease. 
Despite this, awareness and further education for healthcare providers seems like a logical step; 
however, there is no data currently available indicating the level of healthcare provider 
knowledge and ability to deal with the Lyme disease burden.  
 
PHAC has a guidance relationship with the physicians of Canada but does not develop 
therapeutic protocols. It has traditionally provided information for patients and physicians alike. 
While new guidance documents are in the works, they are still months away from completion.  
Dr. Karda had asked for evidence-based documentation indicating the health outcomes and 
costs of Lyme disease in Canada, as well as supporting documentation from the United States, 
where there is more information available. She begins to synthesize the information and realizes 
that increasing funding for acute care management may not result in the best use of money for 
the overall healthcare system in Canada—a communication problem is the underlying issue. 
How will she, as President, ensure all parties involved truly understand PHAC’s role in 
guidance? More so, she now has the opportunity to demonstrate to a large demographic 
PHAC’s ability in monitoring and implementing public health initiatives that will have a lasting 
effect on the population of Canada.  
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During the last governmental regime, PHAC’s role had been diminished, and many employees 
within the organization as well as the public were anticipating positive change and forward 
momentum with the new government. Within the organization there is great hope and optimism 
amongst the different divisions for increased funding, allowing for further research, surveillance, 
outreach, and awareness. Dr. Karda seeks to temper the expectations of staff and an already 
skeptical advocacy group who doubted PHAC’s course of action based on a disagreement 
about the priorities surrounding Lyme disease.  
 
Based on the information provided, she realizes she has three options: 1) increase funding for 
Lyme disease in acute care settings based on the increase in incidences in Canada. This will 
allow her to dampen the push from CanLyme, gain added public support, and satisfy some of 
her staff; 2) increase funding for surveillance measures which will allow her to gather more 
accurate data so that she can later make recommendations based on a comprehensive data set 
and better advise the public, healthcare providers, and advocacy groups; or, 3) provide a 
marginal increase in funding for acute care measures such as medical education seminars for 
physicians while continuing to raise awareness in high risk parks and forests, all while indicating 
that additional funding for passive surveillance measures will help the Agency accumulate 
necessary data. Each option has its pros and cons and success will be based on how the 
message is framed and delivered.  
 
Regardless of Dr. Karda’s decision, it is imperative that she bridge the gap between the 
stakeholders and control the expectations of various parties. She must understand the positions 
of all parties involved while delivering on the Minister’s mandate.  
 
An interesting alternative would be to present options to the department heads in a 
brainstorming session. These approaches are vital to finding out-of-the-box solutions.  
 
CONCLUSION 
PHAC provides leadership and guidance to all the provinces and territories as well as 
healthcare providers and citizens. PHAC is responsible for using evidence-based decision 
making to best protect and prevent against threats to health. PHAC has a chance to make a 
great impact with the new Liberal government in leadership. Responsible decision making and 
impactful guidance is of utmost importance at this pivotal time. Strong leadership and 
communication are crucial. True leadership entails assessing the various options, 
understanding processes, accounting for different viewpoints, and working collaboratively in 
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BACKGROUND 
Increasing cases of Lyme disease are creating public outcry. The Public Health Agency of 
Canada (PHAC) has been tasked with the surveillance and guidance for this tick-borne disease 
but has not seen additional funding. Evidence-based analysis has indicated the most impactful 
use of resources would be spent on prevention and awareness. Despite this information, the 
push for increasing the healthcare budget to allow for more Lyme disease funding is growing. A 
desire to increase resources for acute care in the hopes of better diagnostic testing, more freely 
prescribed antibiotics, and dedicated Lyme clinics is being put forward from advocacy groups. 
As climate change worsens, Lyme incidences rising in the foreseeable future is probable. As the 
president of PHAC, managing different stakeholders within and outside of the organization while 
managing expectations is crucial. The ability to engage and inform while maintaining a positive 
public perception is key, as this will lay the framework for other initiatives to launch in the future. 
Balancing this delicate situation while maintaining an evidence-based approach will take caution 
and strategic skills.  
 
OBJECTIVES 
1. Decision-making thought process.  
2. Discussion around prioritization of resources.  
3. Leadership in difficult situations when there are no definitive right answers.  
 
Creating competing interest groups will be beneficial in dividing the classroom for productive 
debate and conversation.  
 
DISCUSSION QUESTIONS 
1. Is it necessary to appease all parties? 
2. How should one prioritize decisions? 
3. When to discuss and when to decide? 
4. Do we truly understand the issue at hand? Are the right parties involved?  
5. What does the evidence indicate? What is our responsibility to the evidence gathered and 
what is our responsibility to the public in the immediate situation and the future? 
 
KEYWORDS 
Leadership; stakeholders; prioritization; evidence. 
